These are the three that were most commonly used by Medicare Part D patients between June 1, 2022, and May 31, according to an Aug. 29 report from CNBC:
Eliquis, a blood thinner made by Bristol-Myers Squibb, was the most commonly used, with 3.7 million Medicare enrollees on the medication.
Jardiance, a low blood sugar medication for Type 2 diabetes made by Boehringer Ingelheim, was used by 1.6 million people.
Xarelto, a blood thinner made by Johnson & Johnson, was used by 1.3 million beneficiaries.
